| CDTX Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the CDTX shares outstanding history going back to 4/15/2015:
Also see: CDTX Market Cap History CDTX YTD Return |
CDTX Shares Outstanding History — Cidara Therapeutics Share Count Over Time
As of 11/3/2025 Cidara Therapeutics has 31.44 million CDTX shares outstanding. Investors often track the CDTX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows CDTX share count trends over time, with 45 historical shares outstanding datapoints presented, dating back to 4/15/2015.
| CDTX Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CDTX Historical Shares Outstanding: +44.70% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| CDTX Stock Price Chart |
| About Cidara Therapeutics Inc |
| Cidara Therapeutics, Inc. is a biotechnology company. Co. is developing targeted immunotherapies designed for patients facing serious diseases. Co.'s portfolio comprises various treatment and prevention paradigms, including drug-Fc conjugate (DFC) from its Cloudbreak platform targeting oncologic, viral and autoimmune diseases. Co. is focused on advancing Cloudbreak development programs, including its lead oncology candidate, CBO421, as well as advancing other pipeline assets. CBO421 is a development candidate targeting CD73 for the treatment of solid tumors. We show 45 historical shares outstanding datapoints in our coverage of CDTX's shares outstanding history. Understanding the changing numbers of CDTX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like CDTX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching CDTX by allowing them to research CDTX shares outstanding history as well as any other stock in our coverage universe. |
| CDTX Current Stock Quote |
Quotes delayed 20 minutes  Free CDTX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| CDTX Share Performance |
| Shares Outstanding Peers |
| Cidara Therapeutics (CDTX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
CDXC Shares Outstanding History CELC Shares Outstanding History CELG Shares Outstanding History CELL Shares Outstanding History CELU Shares Outstanding History CELZ Shares Outstanding History CEMI Shares Outstanding History CERC Shares Outstanding History CERE Shares Outstanding History CERS Shares Outstanding History More Healthcare companies » |
CDTX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
